Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Reflect ScientificRSCF +6.26% Net Current Asset Value is $0.02 as of Sep. 2025, which is 100% below its 10-year median of 4.10. The stock has 4 warning signs investors should review. Among 569 Medical Devices & Instruments companies, Reflect Scientific ranks better than 82.07% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Reflect Scientific's net current asset value per share for the quarter that ended in Sep. 2025 was $0.02.
The historical rank and industry rank for Reflect Scientific's Net Current Asset Value or its related term are showing as below:
RSCF'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 2.01 Med: 4.1 Max: 50
Current: 2.14
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Reflect Scientific was 50.00. The lowest was 2.01. And the median was 4.10.
RSCF's Price-to-Net-Current-Asset-Value is ranked better than 82.07% of 569
companies
in the Medical Devices & Instruments industry
Industry Median: 4.91
vs RSCF: 2.14
Reflect Scientific (OTCPK:RSCF) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Reflect Scientific Net Current Asset Value Related Terms
Reflect Scientific Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Reflect Scientific's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RSCF vs NXGL, LUCY, GCTK: Net Current Asset Value Comparison
For the Medical Instruments & Supplies subindustry, Reflect Scientific's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Reflect Scientific Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Reflect Scientific's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Reflect Scientific's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of $0.02 mean?
Reflect Scientific (RSCF) has a Net Current Asset Value of $0.02 as of Sep. 2025. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Reflect Scientific and its competitors. This is 100% below median its historical median of 4.10. Over the past decade, Reflect Scientific's Net Current Asset Value has ranged from 2.01 to 50.00. According to the industry distribution chart, Reflect Scientific ranks #102 out of 569 companies in the Medical Devices & Instruments industry, placing it in the top 17.9%.
Is Reflect Scientific's Net Current Asset Value too high?
Reflect Scientific's current Net Current Asset Value of $0.02 is 100% below median its 10-year median of 4.10. Over the past 10 years, this metric has ranged from a low of 2.01 to a high of 50.00. The Medical Devices & Instruments industry median Net Current Asset Value is 4.91. Reflect Scientific's value of $0.02 is 99.6% below this industry median. Based on the distribution chart, Reflect Scientific ranks #102 out of 569 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Reflect Scientific's Net Current Asset Value compare to NXGL and LUCY?
According to the Medical Devices & Instruments industry distribution chart, Reflect Scientific ranks #102 out of 569 companies for Net Current Asset Value. This places Reflect Scientific in the top 18% of its industry — outperforming the majority of peers. The industry median Net Current Asset Value is 4.91. Reflect Scientific's value of $0.02 is 99.6% below this benchmark. Historically, Reflect Scientific's own Net Current Asset Value has ranged from 2.01 to 50.00 over the past decade. While the company's 10-year median is 4.10 vs. the industry median of 4.91, Reflect Scientific has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 4.91, based on 569 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Reflect Scientific's current Net Current Asset Value of $0.02 is 99.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Reflect Scientific and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 4.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Reflect Scientific's current Net Current Asset Value is $0.02, which is 100% below median its own 10-year median of 4.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reflect Scientific stock overvalued right now?
Reflect Scientific (RSCF) has a current Net Current Asset Value of $0.02. The current Net Current Asset Value is $0.02, which is 100% below median its 10-year median of 4.10 and 99.6% below the Medical Devices & Instruments industry median of 4.91. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Reflect Scientific (RSCF), the current Net Current Asset Value is $0.02 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Reflect Scientific Inc is engaged in the manufacture and distribution of products targeted at the life science market. The group's customers include hospitals, diagnostic laboratories, pharmaceutical and biotech companies, cold chain management, universities, government and private sector research facilities, and chemical and industrial companies. Its growing product portfolio includes ultra-low temperature freezers, blast freezers, solvent chillers, and refrigerated transportation in addition to supplying OEM products to the life sciences industry. The group's products are Cryometrix, GCFerrules, and Visacon. It recognizes revenue from the sale of scientific equipment for the life sciences and manufacturing industries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RSCF has been successfully added to your 
